Project Information

Bid Title

81626Y0785-Sole Source with Cepheid

Issuing Agency

City of New York

Location

New York

Published Date

Feb 5, 2026

Closing Date

Feb 18, 2026

Government Level

State & Local

Status

Closed

Ref. #

81626Y0785

Original Source

Join to Access Full Details

Bid Inquiries

Join to Access Full Details

Bid Documents

Join to Access Full Details

Project Description

Program:	DIS - Bureau of Public Health Clinics
Industry:	Goods
EPIN:	81626Y0785
Procurement Name:	81626Y0785-Sole Source with Cepheid
Agency:	DEPARTMENT OF HEALTH AND MENTAL HYGIENE
RFx Status:	Released
Procurement Method:	RFI
Release Date:	2/5/2026 12:00:00 AM
Due Date:	2/18/2026 2:00:00 PM
Main Commodity:	Scientific/Chemical Laboratory Equipment and Supplies

Show / Hide : Summary Summary

EPIN 81626Y0785	Release Date 2/5/2026 12:00:00 AM (Your Local Time)
Estimated Number of Contracts 1.00
Estimated Procurement Value 3,473,064.00
Agency DEPARTMENT OF HEALTH AND MENTAL HYGIENE
Agency Contact First Name Shamecka
Agency Contact Last Name Williams
Agency Contact Email swillia9@health.nyc.gov
Concept Report
RFx Title 81626Y0785-Sole Source with Cepheid
RFx Status Released

Show / Hide : Description Description

Pursuant to Section 3-05 of the New York City Procurement Policy Board Rules, the Department of Health and Mental Hygiene (DOHMH) intends to enter into negotiations for a six-year agreement with Cepheid for the direct purchase of assay kits, reagents, equipment (including service and maintenance), and other needed supplies. These products will be utilized by DOHMH's Public Health Laboratory (PHL) and Sexual Health Clinics for clinical and environmental testing for the detection and identification of carbapenemase, Sexually Transmitted Infections (STIs) and other emerging bacteria, pathogens and viruses, such as Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), COVID-19, mpox, influenza, bird flu, norovirus, trichomonas, tuberculosis and multidrug-resistant superbugs. DOHMH has determined that Cepheid is the sole source provider for the required assay kits, reagents, and equipment (including service and maintenance). Cepheid is the sole manufacturer of Xpert® reagents, and GeneXpert® systems are manufactured exclusively for Cepheid. Xpert reagent test cartridges are designed and manufactured to only be used with Cepheid’s instruments. Cepheid is the only authorized provider of service for GeneXpert systems to customers within the United States, excluding territories. Any firm that believes it can legally provide these goods is invited to submit an Expression of Interest directly to this RFI- EPIN 81626Y0785 no later than 2/18/2026 by 2:00PM. If you need additional assistance with PASSPort, please contact the MOCS Service Desk at https://mocssupport.atlassian.net/servicedesk/customer/portal/8 Pursuant to Section 3-05 of the New York City Procurement Policy Board Rules, the Department of Health and Mental Hygiene (DOHMH) intends to enter into negotiations for a six-year agreement with Cepheid for the direct purchase of assay kits, reagents, equipment (including service and maintenance), and other needed supplies. These products will be utilized by DOHMH's Public Health Laboratory (PHL) and Sexual Health Clinics for clinical and environmental testing for the detection and identification of carbapenemase, Sexually Transmitted Infections (STIs) and other emerging bacteria, pathogens and viruses, such as Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), COVID-19, mpox, influenza, bird flu, norovirus, trichomonas, tuberculosis and multidrug-resistant superbugs. DOHMH has determined that Cepheid is the sole source provider for the required assay kits, reagents, and equipment (including service and maintenance). Cepheid is the sole manufacturer of Xpert® reagents, and GeneXpert® systems are manufactured exclusively for Cepheid. Xpert reagent test cartridges are designed and manufactured to only be used with Cepheid’s instruments. Cepheid is the only authorized provider of service for GeneXpert systems to customers within the United States, excluding territories. Any firm that believes it can legally provide these goods is invited to submit an Expression of Interest directly to this RFI- EPIN 81626Y0785 no later than 2/18/2026 by 2:00PM. If you need additional assistance with PASSPort, please contact the MOCS Service Desk at https://mocssupport.atlassian.net/servicedesk/customer/portal/8

Show / Hide : Key Dates Key Dates

Anticipated Contract Start Date (M/d/yyyy) 11/1/2026

Anticipated Contract End Date (M/d/yyyy) 10/31/2032

Release Date (M/d/yyyy) 2/5/2026

Due Date (M/d/yyyy) 2/18/2026

Bid Opening Date (M/d/yyyy) 12:00:00 AM

Questions Due Date (M/d/yyyy) Agency Users may not respond to your question if it is submitted after this date.

Show / Hide : Documents Documents

Show / Hide : Pre-response/Pre-bid conferences Pre-response/Pre-bid conferences

0 Result(s)

Commodity Codes

• NAICS 325413In-Vitro Diagnostic Substance Manufacturing
• NAICS 334516Analytical Laboratory Instrument Manufacturing

* Disclaimer: Government BidHub provides information on bids, RFPs (Requests for Proposals), and RFQs (Requests for Qualifications) solely for convenience and informational purposes. This site is not an official public notice board. For official details, responses, or inquiries, please contact the relevant government agency directly.